biote (BTMD) Stock Chart & Stock Price History $5.78 -0.32 (-5.25%) (As of 11:51 AM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends biote Stock Price Performance 5 Day Performance-1.29%1 Month Performance+2.01%3 Month Performance+1.50%6 Month Performance-16.44%Year-To-Date Performance+23.48%1 Year Performance+21.03% Receive BTMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for biote and its competitors with MarketBeat's FREE daily newsletter. Email Address If you see ONE chart today… make it this one (Ad)$1 Trillion… That’s how much Big Tech is set to spend on AI investment in the coming months—according to Goldman Sachs. This investment is driving an A.I. boom that’s being felt across many industries… Including a specific group of energy tickers since A.I. data centers use a massive amount of power. One of those tickers is CEG, up nearly 600% in the last 3 years… Combined with the upcoming presidential election, we have the recipe for a major shakeup in the market. You see, each time the U.S. elects a new president, one overlooked part of the energy sector tends to see a big move. Fact is… this energy niche is BOOMING.And expects this underappreciated niche to continue rallying well into 2026. BTMD Stock Chart for Monday, December, 23, 2024 BTMD Chart by TradingView biote Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024$5.76$6.10+5.90%$6.15$5.70340,274 shs$331.46 million12/19/2024$6.18$5.76-6.80%$6.17$5.75138,787 shs$312.98 million12/18/2024$6.35$6.18-2.68%$6.60$6.09229,725 shs$335.80 million12/17/2024$6.39$6.35-0.63%$6.52$6.2590,925 shs$345.04 million12/16/2024$6.37$6.39+0.31%$6.70$6.39236,321 shs$347.21 million12/13/2024$6.54$6.37-2.60%$6.55$6.2158,711 shs$346.15 million Get the Latest News and Ratings for BTMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for biote and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024$6.67$6.54-1.95%$6.68$6.5370,526 shs$355.36 million12/11/2024$6.75$6.67-1.19%$6.78$6.6087,179 shs$362.43 million12/10/2024$6.67$6.75+1.20%$6.90$6.58150,258 shs$366.78 million12/09/2024$6.43$6.67+3.73%$6.78$6.40168,819 shs$362.45 million12/06/2024$6.42$6.43+0.16%$6.48$6.3176,526 shs$349.39 million12/05/2024$6.59$6.42-2.58%$6.60$6.3399,497 shs$348.86 million12/04/2024$6.63$6.59-0.60%$6.65$6.3999,411 shs$358.10 million12/03/2024$6.93$6.63-4.33%$6.96$6.56159,934 shs$360.27 million12/02/2024$6.61$6.93+4.84%$6.98$6.57147,007 shs$376.56 million11/29/2024$6.68$6.61-1.05%$6.69$6.5241,680 shs$359.17 million11/28/2024$6.68$6.68$6.78$6.52110,082 shs$362.99 million11/27/2024$6.69$6.68-0.15%$6.78$6.52110,082 shs$362.99 million11/26/2024$6.34$6.69+5.52%$6.71$6.25180,135 shs$363.54 million11/25/2024$5.98$6.34+6.02%$6.50$5.99258,382 shs$344.52 million11/22/2024$6.14$5.98-2.61%$6.25$5.94308,898 shs$324.24 million Related Companies Ocular Therapeutix Stock Price Chart Travere Therapeutics Stock Price Chart Mesoblast Stock Price Chart Intellia Therapeutics Stock Price Chart Praxis Precision Medicines Stock Price Chart Arvinas Stock Price Chart Day One Biopharmaceuticals Stock Price Chart Spyre Therapeutics Stock Price Chart Ardelyx Stock Price Chart Calliditas Therapeutics AB (publ) Stock Price Chart Receive BTMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for biote and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BTMD) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding biote Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share biote With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
